The event is an Earnings Conference Call for Investors/Analysts.
The call is scheduled for Friday, November 06, 2026, at 18:30 hours IST and is expected to last for 60 minutes.
The stated purpose is to discuss the Company's financial performance and business updates for the quarter and half year ended September 30, 2026 (Q2 FY27).
The document does not specify if the meeting is scheduled before or after an official earnings announcement.
Management participants are not listed by name or designation in the disclosure.
The audio recording and transcript of the conference call will be made available on the company's website at www.glandpharma.com after the call.
The disclosure does not contain any explicit statement regarding the sharing of unpublished price sensitive information (UPSI).
Additional Notes Section
The document is an intimation letter addressed to BSE Limited and the National Stock Exchange of India Limited.
The letter includes an enclosure titled "EARNINGS CONFERENCE CALL FOR Q2 FY27" which provides dial-in information.
No financial data, guidance references, or presentation summaries were disclosed in this announcement.
Logistical details (dial-in numbers, toll-free numbers, registration link) were provided for operational access to the call.
